The detrimental effect of quantity of smoking on survival in progressive fibrosing ILD - 04/03/22
, J.J. van der Vis a, b, K.M. Kazemier a, c, J.C. Grutters a, d, C.H.M. van Moorsel a, dAbstract |
Background and objective |
Patients with progressive fibrosing interstitial lung disease (PF-ILD) are prone to early mortality compared with other phenotypes of ILD. The possible effect of smoking on survival has not been investigated yet. Furthermore, it is unknown what the effect of quantity of smoking is in PF-ILD. In this study, it was determined if quantity of smoking is associated with worse survival in patients with PF-ILD.
Methods |
Patients meeting the INBUILD trial-criteria for PF-ILD were included in this retrospective cohort study. Pack year (py) was tested as a prognostic variable with a multivariable Cox proportional hazard model. Also, median transplant-free survival was compared between heavy (≥20 pys) and mild-moderate smokers (0.1–19.9 pys).
Results |
In PF-ILD (N = 377), the unadjusted and adjusted hazard ratio for py were significant, (1.014, 95% confidence interval (CI): 1.006–1.022, P < 0.001; 1.011, CI:1.002–1.021, P = 0.022 respectively). This translates to an 11%, 22%, or 44% higher risk for mortality for patients accumulating 10, 20 or 40 pys, respectively. Heavy smokers demonstrated a median transplant-free survival of 3.0 years, which was significantly reduced compared with mild-moderate smokers (3.8 years, P = 0.035). Additionally, more patients with emphysema were heavy smokers (N = 68) than never (N = 5, P < 0.001) or mild-moderate smokers (n = 21, p < 0.001).
Conclusion |
In PF-ILD, a pack year is associated with an increased risk of mortality. Furthermore, quantity of smoking is associated with worse survival and higher prevalence of emphysema. Our data indicates that limiting amount of pys will provide a survival benefit in patients developing PF-ILD.
Le texte complet de cet article est disponible en PDF.Highlights |
• | In PF-ILD, heavy smokers (≥20 pack years) demonstrate worse transplant-free survival compared with mild-moderate (0.1–19.9 pack years) and never smokers. |
• | A single pack year is associated with increased risk for mortality after adjusting for age, male gender, baseline pulmonary function tests and a diagnosis of idiopathic pulmonary fibrosis. |
• | In PF-ILD, emphysema on HRCT was most prevalent in heavy smokers compared with mild-moderate and never smokers. |
Keywords : Smoking, Pulmonary fibrosis, Progressive fibrosing ILD, Pack year
Plan
Vol 194
Article 106760- avril 2022 Retour au numéro
Article précédent
- Therapeutic applications of capsaicin in humans to target conditions of the respiratory system: A scoping review
- Nour Toukan, Stefan Tino Kulnik, Agnieszka Lewko, Amr ElShaer
- Time to active sitting position: One-year findings from a temporary COVID-19 intensive care unit
- Veronica Rossi, Cesare Del Monaco, Simone Gambazza, Martina Santambrogio, Filippo Binda, Mariangela Retucci, Emilia Privitera, Marco Mantero, Nicola Bottino, Dario Laquintana, Francesco Blasi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?